CBI Health

Site: Burlington

Service: Driver Assessment Services

Record #: BTN4895
Last Full Update: 03 Dec 2024

Memos and Bulletins

Public Comments

This centre is approved to conduct medical assessments only, not Class "G" Vision Waiver Function Assessments

  • for other approved centres see Ontario Ministry of Transportation list here

Contact Information

Toll Free Phone 1-800-558-4599
Fax 1-855-687-0471
E-Mail drt_ontario@cbihealth.ca
Website www.cbihealth.ca/drtprogram
Contact Form www.cbihealth.ca/contact-us
Social Media Facebook Facebook, Instagram Instagram, LinkedIn LinkedIn, X (Twitter) X (Twitter)

Site Information

Located In Community Burlington
Address & Map
450 Appleby Line, Unit 14
Burlington, ON L7L 2Y2
 
View Google Map
Intersection Appleby Line and New St
Physical Access Partially Accessible - no automatic button for door, has ringer for assistance

Agency Information

Description (Agency)

Driver rehabilitation centre approved by the Ministry of Transportation for driving evaluations and driving rehabilitation

Legal Status (60) Commercial
Funding Fees

Description and Service Details

Description (Service)

Driver rehabilitation centre approved by the Ministry of Transportation (MTO) for driving evaluations and driving rehabilitation

  • approved to conduct driving evaluations to determine medical fitness to drive
  • also provides assessment and treatment related to driver and passenger anxiety and vehicle modifications
Hours

Mon-Thu 8 am-8 pm, Fri 8 am-5 pm

Areas Served Burlington ; Hamilton (City of)
Eligibility No restrictions
Application

Contact for information

Languages English
Fees Service

Categories and Classification

Service Categories Driving Evaluation
Older Adult Main Categories DRIVING & TRANSPORTATION ; MEMORY LOSS & DEMENTIA
Older Adult Sub-Categories Driving Assessment ; Driving Training/Assessments

Any omissions are unintentional and HIP disclaims any liability for unauthorized use or reproduction of any portion of this site. For a complete copyright and license statement please refer to our Terms of Use.